Johnson & JohnsonvsVericel

JNJ and VCEL stock compared: price, dividend, valuation and results, from SEC filings.

VCEL

Vericel Corporation

$57.48

Value $2.9B

+0.91%
VCEL's page

Johnson & Johnson (JNJ) has a market value of $681B and Vericel (VCEL) $2.9B. Over the last year, with dividends, JNJ moved +47.5% and VCEL +44.2%. The P/E is 42.3 for JNJ and 87.6 for VCEL. Dividend yield: JNJ 1.87%, VCEL none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$681B

    VCEL$2.9B

    JNJ is 233 times VCEL

  • Revenue, 12 months

    JNJ$99.3B

    VCEL$324M

    JNJ is 306 times VCEL

  • Net income, 12 months

    JNJ$16.1B

    VCEL$33M

    JNJ is 483 times VCEL

  • Operating margin

    JNJ–

    VCEL8.3%

  • ROIC

    JNJ12.4%

    VCEL6.0%

    6.4 points apart

  • P/E

    JNJ42.3

    VCEL87.6

    VCEL is 2.1 times JNJ

  • Dividend yield

    JNJ1.9%

    VCEL0.0%

    1.9 points apart

  • 5-year return

    JNJ+98.6%

    VCEL+39.0%

    59.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+98.6%

VCEL+39.0%

5010015020020222023202420252026
Returns by period
PeriodJNJWith dividendsVCELWith dividends
1 year since November 14, 2025+47.5%Price +44.2%+44.2%Price +44.2%
3 years since November 16, 2023+105.0%+27.0% a yearPrice +88.2%+61.6%+17.3% a yearPrice +61.6%
5 years since November 15, 2021+98.6%+14.7% a yearPrice +72.8%+39.0%+6.8% a yearPrice +39.0%
10 years since November 16, 2016+218.6%+12.3% a yearPrice +142.8%+2,246.1%+37.1% a yearPrice +2,246.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonVCELVericel

Valuation

JNJVCEL
Valuation
Price$282.55$57.48
Market value$681B$2.9B
Enterprise value (EV)$708B–
P/E42.387.6
P/E, 5-year median21.9–
P/B8.47.6
EV/EBIT39.9–
Free cash flow yield3.0%2.0%

Results and growth

JNJVCEL
Results and growth
Revenue, 12 months$99.3B$324M
Net income, 12 months$16.1B$33M
Free cash flow, 12 months$20.6B$58M
Earnings per share, 12 months$6.59$0.64
Revenue growth, year on year6.1%16.5%
Revenue growth a year, past+2.7%over 5 years+17.8%over 5 years
EPS growth a year, past+14.9%over 5 years+39.8%over 5 years

Margins and returns on capital

JNJVCEL
Margins and returns on capital
Gross margin67.6%74.5%
Operating margin–8.3%
Net margin16.2%10.3%
ROIC12.4%6.0%
ROE19.7%9.3%

Balance sheet

JNJVCEL
Balance sheet
Cash$17.2B$170M
Total debt$44.7B–
Net debt / EBITDA1.1–
Interest cover18.0×42.0×

Dividends and buybacks

JNJVCEL
Dividends and buybacks
Dividend yield1.9%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%–
Shareholder yield2.7%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or VCEL

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Vericel?

By market value, Johnson & Johnson ($681B) is about 233.4 times Vericel ($2.9B), at today's prices.

How did JNJ and VCEL stock do over the last 10 years?

Since November 16, 2016, JNJ's price moved +142.8% and VCEL's +2,246.1%. With dividends: JNJ +218.6% (+12.3% a year), VCEL +2,246.1% (+37.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or VCEL?

The dividend yield at today's price is 1.87% for Johnson & Johnson and none for Vericel. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and VCEL?

At today's price, the P/E is 42.3 for JNJ and 87.6 for VCEL. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Johnson & Johnson or Vericel?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 10.3% for Vericel, and the operating margin – and 8.3%. Revenue was $99.3B and $324M.

Which is the better investment, Johnson & Johnson or Vericel?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.